Abstract
This article narrates the potential role of sesame oil-based Anu taila for respiratory health and the prevention of COVID-19. Ayurveda recommends the use of sesame oil and A. taila as a part of daily routine (dinacharya) for oral gargling and transnasal application (Nasya) for preventing upper respiratory tract infections. Recent studies on COVID-19 have elucidated the activity of certain fatty acids in restricting viral binding. Based on the evidence gathered from in-silico, pre-clinical, and pharmacological studies as well as references from classical textbooks of Ayurveda, this article infers that the transnasal application of sesame oil and/or A. taila could provide resilience/protection to the respiratory system. It can act as a ‘biological mask’ to prevent respiratory infections like COVID-19. Detailed pharmacological study can give fuller confirmation of our informed “inference” that A. taila offers a cost-effective intervention for the prevention of COVID-19 like infections of the upper respiratory tract.
Keywords: Sesame oil & Anu taila, Respiratory health, COVID-19 prevention, Fatty acids, Ayurveda
1. Background
Since the outbreak of SARS-CoV-2, the cases of respiratory infections skyrocketed causing 278 million incidents and 5.4 million deaths globally between 2019 and 2021 [1]. The discovery of vaccines has resulted in a significant reduction in mortality [2,3]. However, despite the vaccine's efficacy, the re-emergence of resistant strains and breakthrough infections makes prevention quite challenging [[4], [5], [6]]. In India, the rate of breakthrough COVID-19 infections in fully vaccinated individuals was reported to be 4–6% [7,8]. Hence, long-term general and efficient respiratory preventive solutions even beyond the current pandemic are a public health priority.
Recent research has looked at the use of fatty acids for possible antiviral effects against COVID-19 [[9], [10], [11]]. Omega-3 fatty acids such as alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and its derivatives were used in several inflammation-associated chronic respiratory diseases [12,13]. Similar exploration was done during the SARS, MERS and other viral infections, elucidating the mechanism of fatty acid-binding to viral proteins [[14], [15], [16]]. During SARS-CoV-2, a study performed at the start of 2020 attempted to investigate the activity of natural product compounds against the viral proteins. It was seen that the interaction between phytoestrogens (like Diadiazin, Genistein, Formontein, and Biochanin-A) and fatty acids (like palmitic acid, linoleic acid, and chlorogenic acids) with host viral recognition site SBDβ resulted in antagonistic activity against viral binding [17]. Following this, Toezler et al., performed a noteworthy in-silico molecular docking study of an essential fatty acid, linoleic acid against viral proteins [18]. Computational analysis showed that linoleic acid exhibited excellent and strong interaction at all the 3 binding sites of the SARS-CoV-2 spike proteins. Toezler et al. further verified the intensity of Spike protein-ACE2 binding in an in-vitro model. An interaction with linoleic acid caused a conformational change in the viral protein to a locked S structure that reduced the affinity of binding with host ACE2 receptors. It was also seen that no mutations of the viral genome resulted in any changes in the binding site for linoleic acid. Further, when epithelial cells infected with SARS-COV-2 were treated using various doses of remdesivir, the presence of linoleic acid provided a synergistic action in antiviral activity despite the dosage. Therefore, a low dose of Remdesivir was sufficient in treating infection in presence of linoleic acid [18]. Subsequent to this, another group investigated the interaction of spike proteins with 17 polyunsaturated free fatty acids (PUFA). From the docking, PUFAs like linoleic acid, eicosapentaenoic acid, and linolenic acid interfered with ACE2 receptors of the virus significantly, preventing its binding to the host ACE2 receptors. Similar to the outcomes by Toezler et al., linoleic acid among others showed excellent inhibition in the binding of the RBD sequence of SARS-CoV-2 with ACE2 receptors. Interestingly, two other PUFAs, linolenic acid, and eicosapentaenoic acid also reduced the activity of host proteases (TMPRSS2 and cathepsin L) that activate spike proteins, thus reducing the affinity of binding with ACE2 receptors and inhibiting the viral entry [19]. Several studies on SARS-CoV-2 have also shown similar involvement of fatty acids as potent antivirals for SARS-CoV-2 [[20], [21], [22]]. These studies indicate the ability of essential fatty acids, especially linoleic acid, as a notable compound inhibiting viral binding and interactions. An electron micrograph on linoleic acid has also shown that a concentration of 1 mg/ml of linoleic acid is capable of completely disrupting the viral envelope, inactivating the viral activity [23].
Few studies have accessed the fatty acids from whole oils too. In a computational analysis on the activity of sesame oil and its compounds against the SARS-CoV-2 viral proteins, 6 compounds from the oil had higher affinity compared to the currently used M-pro inhibitor, darunavir, against viral M-pro, and an equivalent docking score compared to the standard drug, remdesivir in RdRp binding [24]. A similar study on seed proteins including sesame oil reported key molecules of sesame (Sesamin, sesaminol, sesamolin) having significantly good interaction with 3 important viral proteins (spike protein, M-pro, and ACE receptor site) [25]. Likewise, in a study conducted on all the fatty acids of coconut oil against viral proteins [26], fatty acids like capric acid, caprylic acid, lauric acid, linoleic acid, myristic acid, oleic acid, palmitic acid, and oleic acid exhibited good inhibition against 6 proteins of SARS-CoV-2 in binding to the host receptors. Surprisingly, despite the abundance of lauric acid (44%) in coconut oil, a stronger affinity was seen with linoleic acid(1%) against 5 of the 6 SARS-CoV-2 protein targets [26]. Interestingly, sesame oil consists of about 41–48% linoleic acid and is the most abundant fatty acid seen in sesame oil in addition to other fatty acids like oleic acid (35–42%), palmitic acid (7–9%), and stearic acid (4–5%) [27].
2. Anu taila for respiratory health
Independent of these scientific explorations of oils against infections that began only in the late 20th century, Ayurveda has based on its theoretical framework (Dosha Vichar) practiced the use of oils for prevention and protection against the entry of external agents for centuries [28]. Some commonly used oils for nasopharyngeal protection include Sesame oil, Coconut oil, and Castor oil [29]. Of these, sesame oil (Tila taila), extracted from the plant Sesamum indicum, Linn, known as “queen of oil seeds” is given paramount importance in nasopharyngeal and other medicinal applications [[30], [31], [32]]. Application of pure sesame oil trans-nasally improved linings of nasal mucosa preventing mucosal dryness [33], attenuating edema and neutrophilic inflammation in lungs [34], and offering protection of the upper respiratory tract [35]. The presence of PUFAs, and phytochemicals makes sesame a rich source of antioxidants, with longer stability, high resistance to oxidation, and rancidity [36]. Its application as antioxidant, anti-carcinogenic, analgesic, anti-bacterial, and anti-inflammatory agent are also well-known [[37], [38], [39]].
For respiratory health, as prophylaxis, Ayurveda specifically advocates the use of sesame oil-based medicated oils like A. taila (sesame oil infused with 25 other herbs) and Murchitatila taila (sesame oil infused with herbs and processed by a method called ‘Murchana’) as transnasal and oral lubricants [40]. Particularly, A. taila is recommended in classical texts to be used as part of dinacharya (daily regimen) for transnasal application (Nasya) [40,41]. It is said to strengthen all the sense organs and is used for diseases above the clavicle (urdwajatrugata: urdwa-above, Jatru-clavicle) including upper respiratory diseases [40]. The method of preparation A. taila includes a technique called Murchana will be seen as an extremely innovative process by technologists. The oil is repeatedly boiled with the herbal decoction (of more than 25 herbs) 9 times and during the 10th time, goats' milk is added to the mixture. A study investigated the physicochemical changes in oils after the process of ‘murchana’. It was seen that murchana oils prepared as per ayurvedic classical method showed higher saponification, refractive index, decreased iodine, free fatty acids, and peroxide levels and dramatically improve the stability i.e., reduce the onset of rancidity, compared to unprocessed oils. The Murchana process increased the bioavailability of low molecular weight fatty acids, thus facilitating easy absorption by the body [42]. When the classical method of oil preparation was replaced with a deviated method of preparation, an increased peroxide level was seen [43]. Whereas, the classical form of preparation showed better dissolution of herbal components, an unaltered fatty acid profile of sesame oil, and high intensity of herbal components [43]. These experiments highlight the Ayurvedic system's keen use of advanced processing methods for enhanced functionality of medicated sesame oil, A. taila. Furthermore, Duraipandi et al. [44] identified that the active polar botanical ingredients (ABIs) of A. taila were found embedded in a network of vesicular structures of the lipid base to form a nano-drug delivery system. Thus efficiently delivering water-soluble ingredients across barriers [44].
During the outbreak of SARS-CoV-2, Ministry of AYUSH, Govt. of India, guidelines also recommended the use of sesame oil or A. taila for transnasal application and oral swishing as a preventive guideline [32]. An insightful study showed that SARS-CoV-2 infected hamsters when treated with either pure sesame oil or A. taila through the transnasal route, there was a significant reduction in the pro-inflammatory cytokines Th1 and Th-17 in both groups. A better reduction in the rate and severity of infection, and pneumonitis symptoms when A. taila was used [43]. Nasal mucosa exhibits the highest ACE2 expression and is the origin of viral transmission [20]. Therefore, the use of sesame oil or A. taila as transnasal usage (Nasya) might avoid the adherence of the virus possibly by forming a biofilm [29,30]. Though studies on A. taila are limited, we can speculate from the above studies that medicated A. taila has significantly better activity than pure sesame oil in respiratory health. It will be an intriguing exploration to determine the activity and composition of all the fatty acids from sesame oil and A. taila against SARS-CoV-2.
3. Chemical profiling of sesame oil, Anu taila and Murchitatila taila
The authors of this paper conducted a pilot experiment to determine the fatty acid compositional profile of pure sesame oil, A. taila, and Murchitatila taila using Gas Chromatography (GC) (Shimadzu), RT 2560 column (100 m, 0.25 mm id, 0.20 μm df, 250 °C max temperature) with Helium as carrier gas (flow rate 1 ml/min). We detected high amounts of oleic and linoleic acid (polyunsaturated essential fatty acid) in addition to significant levels of palmitic acid and stearic acid from pure sesame oil. Murchitatila taila, prepared using sesame oil by a special process called ‘Murchana’ showed little variation in fatty acid composition as compared to native sesame oil primarily in terms of concentration of palmitic and oleic acid. While the amount of linoleic acid was found to have slight increase which can be considered significant. A. taila showed minimal variations in the composition of free fatty acids compared to sesame oil, despite its complex 10 steps preparative process. The presence of additional fatty acids such as medium-chain capric acid, caproic acid, lauric acid, long-chain myristic acid, and lignoceric acid was also seen (Table 1). A. taila along with herbs also consists of goat's milk and traces of coconut oil as its ingredient. Goat's milk is known for its anti-viral effects and its use in the treatment of many chronic respiratory diseases [43]. These additional ingredients presumably be the source of imparting additional fatty acids detected in A. taila which were originally absent in sesame oil. To validate absence of any adulterant in these oils we also compared the fatty the composition with some of market refined and cold pressed sesame oil samples and found the composition to be significantly in alignment with the literature reports [45]. Few studies also report the antiviral properties of goat's milk in COVID-19 [46]. A comparative analysis of fatty acid profile of goat's milk with sesame oil, A. taila and murchita tila taila showed the presence of four fatty acids viz. n-Caproic acid (C6), Capric acid (C10), Lauric acid (C12) and Myristic acid (C14) in both A. taila and goat's milk (Table 2). The fatty acid profile of goat's milk was obtained from previous research works [47,48]. Among these, n-Caproic acid (C6), Capric acid (C10) and Lauric acid (C12) were absent in both sesame oil and murchita tila taila indicating the importance of adding goat's milk in A. taila preparation. Also, the presence of Myristic acid (C14) in murchitatila taila indicate that it may be coming from other ingredients as well and further studies are needed to confirm this observation. Similarly, detailed analysis is required to understand the source of fatty acids like cis-13-Octadecenoic acid (C18:1-cis-13), cis-11,14-Eicosadienoic acid 8,11-Octadecadienoic acid and Lignoceric acid (C24) that were found only in A. taila and not in sesame oil, murchitatila taila and goat's milk.
Table 1.
Composition of fatty acids in pure sesame oil, and medicated oils (Anu tail and Murchitatila taila).
Shaded values are signifying fatty acids present in high concentrations for ex. Palmolive, Stearic, Oleic, Linoleic acids and nutritionally important fatty acids Ex. Linolenic acid: which is an omega-3 fatty acid.
Table 2.
Comparative analysis of fatty acid profile of goat's milk with sesame oil, Anu taila and murchita tila taila.
The highlighted fatty acids signify common candidates between Goat’s milk and Anu Taila presumably indicating that those fatty acids might have been incorporated to Anu Taila from Goat's milk
While this experiment does not validate the application of A. taila in SARS-CoV-2, it does signify the retained and enhanced expression of many fatty acids seen in sesame oil, including linoleic acid. Thus, administering A. taila could provide better resilience of respiratory health.
From the studies discussed above on fatty acids, we can infer that linoleic acid, abundantly seen in sesame oil, consists of potent antiviral activities against viral binding and infection. Further, recent experimental explorations on sesame oil and A. taila, signify the retained, unaltered and enhanced functionality of A. taila in respiratory health. We can reasonably infer that the use of sesame oil and A. taila as transnasal therapy could play a role of primary protection, and act as a “biological Mask” against SARS-CoV-2 infection and for general protection of the upper respiratory system against various infections.
4. Conclusion
This article intends to inform the public and the scientific world about the safety in use of sesame oil and A. taila as transnasal therapies for respiratory health. Furthermore, the article makes an informed inference based on supportive Ayurveda derived as well as scientific evidence that it can serve as a biological mask.
While physical masks and shields should certainly be used for protection, transnasal installation of medicated oils like A. taila or pure sesame oil will help in providing additional and effective nasopharyngeal protection. The idea of a biological mask is also a simple and practical measure.
Source of funding
Rural India Support Trust (RIST) for establishing the analytical facility at TDU and for salary support for researchers.
Conflicts of interest
Prof. Darshan Shankar is the Vice Chancellor of TDU. He was not involved in the peer review process and editorial decisions related to this paper.
Author contribution
Bhavya Vijay: Investigation, Writing-original draft preparation. Batul Diwan: Investigation, Methodology, Writing-original draft preparation. Poornima Devkumar: Supervision, Writing - review and editing. Prasan Shankar: Supervision, Writing - review and editing, conceptualization. Chethala N Vishnuprasad: Supervision, Writing - review and editing, Formal analysis, Conceptualization. Gurmeet Singh: Conceptualization, Supervision, Writing - review and editing, Formal analysis, Funding acquisition. Deepshikha Kataria: Investigation, Writing - review and editing. Darshan Shankar: Conceptualization, Supervision, Writing - review and editing.
Acknowledgment
The authors acknowledge the financial support received from Rural India Support Trust (RIST) for establishing the analytical facility at TDU and for salary support for researchers.
Footnotes
Peer review under responsibility of Transdisciplinary University, Bangalore.
References
- 1.WHO COVID-19 weekly epidemiological update. World Heal Organ. 2021:1–23. [Google Scholar]
- 2.Liang L.L., Kuo H.S., Ho H.J., Wu C.Y. COVID-19 vaccinations are associated with reduced fatality rates: evidence from cross-county quasi-experiments. J Glob Health. 2021 doi: 10.7189/JOGH.11.05019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jabłońska K., Aballéa S., Toumi M. The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health. 2021 doi: 10.1016/j.puhe.2021.07.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385:1474–1484. doi: 10.1056/NEJMOA2109072/SUPPL_FILE/NEJMOA2109072_DATA-SHARING.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wang S.Y., Juthani P.V., Borges K.A., Shallow M.K., Gupta A., Price C., et al. Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era. Lancet Microbe. 2022 doi: 10.1016/s2666-5247(21)00306-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Excler J.L., Saville M., Berkley S., Kim J.H. Vaccine development for emerging infectious diseases. Nat Med. 2021 274 2021;27:591–600. doi: 10.1038/s41591-021-01301-0. [DOI] [PubMed] [Google Scholar]
- 7.Maurya D., Kaur A., Faraz F., Tandon S., Rana A., Grover S. Assessment of breakthrough infections among post-vaccinated healthcare workers in a Tertiary Dental Hospital in New Delhi, India. medRxiv. 2021 doi: 10.1101/2021.11.15.21266333. [DOI] [Google Scholar]
- 8.Singh U.B., Rophina Mercy, Chaudhry R., Senthivel V., Bala Kiran, Bhoyar Rahul C., et al. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India. J Med Virol. 2021 doi: 10.1002/JMV.27461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Aryan H., Saxena A., Tiwari A. Correlation between bioactive lipids and novel coronavirus: constructive role of biolipids in curbing infectivity by enveloped viruses, centralizing on EPA and DHA. Syst Microbiol Biomanufacturing. 2021 doi: 10.1007/s43393-020-00019-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hathaway D., Pandav K., Patel M., Riva-Moscoso A., Singh B.M., Patel A., et al. Omega 3 fatty acids and COVID-19: a comprehensive review. Infect Chemother. 2020;52:478–495. doi: 10.3947/IC.2020.52.4.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hoang T. An approach of fatty acids and resveratrol in the prevention of COVID-19 severity. Phyther Res. 2021 doi: 10.1002/ptr.6956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Whyand T., Hurst J.R., Beckles M., Caplin M.E. Pollution and respiratory disease: can diet or supplements help? A review. Respir Res. 2018 May 2;19(1):79. doi: 10.1186/s12931-018-0785-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhu X., Wang B., Zhang X., Chen X., Zhu J., Zou Y., et al. Alpha-linolenic acid protects against lipopolysaccharide-induced acute lung injury through anti-inflammatory and anti-oxidative pathways. Microb Pathog. 2020 Feb 18;142 doi: 10.1016/j.micpath.2020.104077. [DOI] [PubMed] [Google Scholar]
- 14.Anderson M., Fritsche K.L. (n-3) fatty acids and infectious disease resistance. J Nutr. 2002 doi: 10.1093/jn/132.12.3566. [DOI] [PubMed] [Google Scholar]
- 15.Park J.E., Gallagher T. Lipidation increases antiviral activities of coronavirus fusion-inhibiting peptides. Virology. 2017 doi: 10.1016/j.virol.2017.07.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Das U.N. Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: a review. J Adv Res. 2018 doi: 10.1016/j.jare.2018.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Elfiky A.A. Natural products may interfere with SARS-CoV-2 attachment to the host cell. J Biomol Struct Dyn. 2021;39:3194–3203. doi: 10.1080/07391102.2020.1761881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Toelzer C., Gupta K., Yadav S.K.N., Borucu U., Davidson A.D., Williamson M.K., et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science. 2020;370:725–730. doi: 10.1126/SCIENCE.ABD3255/SUPPL_FILE/ABD3255S4.MP4. (80-) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Goc A., Niedzwiecki A., Rath M. Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci Rep. 2021 111 2021;11(1) doi: 10.1038/s41598-021-84850-1. 12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Takabayashi T., Yoshida K., Imoto Y., Schleimer R.P., Fujieda S. Regulation of the expression of SARS-CoV-2 receptor angiotensin-converting enzyme 2 in nasal mucosa. Am J Rhinol Allergy. 2022 doi: 10.1177/19458924211027798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Vivar-Sierra A., Araiza-Macías M.J., Hernández-Contreras J.P., Vergara-Castañeda A., Ramírez-Vélez G., Pinto-Almazán R., et al. In silico study of polyunsaturated fatty acids as potential sars-cov-2 spike protein closed conformation stabilizers: epidemiological and computational approaches. Molecules. 2021 doi: 10.3390/molecules26030711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Baral P.K., Amin M.T., Rashid M.M.O., Hossain M.S. Assessment of polyunsaturated fatty acids on COVID-19-associated risk reduction. Rev Bras Farmacogn. 2021 doi: 10.1007/s43450-021-00213-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Thormar H., Isaacs C.E., Brown H.R., Barshatzky M.R., Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1987 doi: 10.1128/AAC.31.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Allam A.E., Amen Y., Ashour A., Assaf H.K., Hassan H.A., Abdel-Rahman I.M., et al. In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp. RSC Adv. 2021;11:22398–22408. doi: 10.1039/D1RA03937G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wong F.-C., Ong J.-H., Chai T.-T. SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: an in silico study. Phytomedicine Plus. 2021;1 doi: 10.1016/J.PHYPLU.2020.100016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Khairan K., Idroes R., Tumilaar S.G., Tallei T.E., Idroes G.M., Rahmadhany F., et al. Molecular docking study of fatty acids from Pliek U Oil in the inhibition of SARS-CoV-2 protein and enzymes. IOP Conf Ser Mater Sci Eng. 2021;1087 doi: 10.1088/1757-899X/1087/1/012058. [DOI] [Google Scholar]
- 27.Wacal C., Ogata N., Basalirwa D., Sasagawa D., Kato M., Handa T., et al. Fatty acid composition of sesame (Sesamum indicum L.) seeds in relation to yield and soil chemical properties on continuously monocropped upland fields converted from paddy fields. Agronomy. 2019 doi: 10.3390/agronomy9120801. [DOI] [Google Scholar]
- 28.Madhukar L.S., Nivrutti B.A., Bhatngar V., Bhatnagar S. Physio-anatomical explanation of abhyanga: an ayurvedic massage technique for healthy life. J Tradit Med Clin Naturop. 2018 doi: 10.4172/2573-4555.1000252. [DOI] [Google Scholar]
- 29.Tillu G., Chaturvedi S., Chopra A., Patwardhan B. Public health approach of Ayurveda and Yoga for COVID-19 prophylaxis. J Altern Complement Med. 2020;26:360–364. doi: 10.1089/ACM.2020.0129/ASSET/IMAGES/LARGE/ACM.2020.0129_FIGURE1.JPEG. [DOI] [PubMed] [Google Scholar]
- 30.Rizvi Z.A., Tripathy M.R., Sharma N., Goswami S., Srikanth N., Sastry J.L.N., et al. Effect of prophylactic use of intranasal oil formulations in the hamster model of COVID-19. Front Pharmacol. 2021, 14;12:746729. doi: 10.3389/fphar.2021.746729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Shanbhag V.K.L. Oil pulling for maintaining oral hygiene – a review. J Tradit Complement Med. 2017;7:106. doi: 10.1016/J.JTCME.2016.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ministry of Ayurveda, Yoga & Naturopathy, Unani S and H (AYUSH). Immunity boosting measures for self care during covid 19 crisis. [n.d].
- 33.Johnsen J., Bratt B.M., Michel-Barron O., Glennow C., Petruson B. Pure sesame oil vs isotonic sodium chloride solution as treatment for dry nasal mucosa. Arch Otolaryngol Head Neck Surg. 2001;127:1353–1356. doi: 10.1001/ARCHOTOL.127.11.1353. [DOI] [PubMed] [Google Scholar]
- 34.Hsu D.Z., Liu C.T., Chu P.Y., Li Y.H., Periasamy S., Liu M.Y. Sesame oil attenuates ovalbumin-induced pulmonary edema and bronchial neutrophilic inflammation in mice. BioMed Res Int. 2013;2013 doi: 10.1155/2013/905670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Rasool S.T., Alavala R.R., Kulandaivelu U., Sreeharsha N. Non-invasive delivery of nano-emulsified sesame oil-extract of turmeric attenuates lung inflammation. Pharmaceutics. 2020 doi: 10.3390/pharmaceutics12121206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Fan Wen, Zeng J, Xu Y. A theoretical discussion of the possibility and possible mechanisms of using sesame oil for prevention of 2019-nCoV (Wuhan coronavirus) from the perspective of colloid and interface science. Pre-Print n.d. 10.13140/RG.2.2.31786.98248. [DOI]
- 37.Pathak N., Rai A.K., Kumari R., Bhat K.V. Value addition in sesame: a perspective on bioactive components for enhancing utility and profitability. Pharmacogn Rev. 2014;8:147. doi: 10.4103/0973-7847.134249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Narasimhulu C.A., Selvarajan K., Litvinov D., Parthasarathy S. Anti-atherosclerotic and anti-inflammatory actions of sesame oil. J Med Food. 2015;18:11. doi: 10.1089/JMF.2014.0138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Jayaraj P., Narasimhulu C.A., Rajagopalan S., Parthasarathy S., Desikan R. Sesamol: a powerful functional food ingredient from sesame oil for cardioprotection. Food Funct. 2020;11:1198–1210. doi: 10.1039/C9FO01873E. [DOI] [PubMed] [Google Scholar]
- 40.Dutta Chakrapani. Commnetary on Charaka Samhita Sootrasthana. vol. 5. [n.d].
- 41.Ahmad S., Zahiruddin S., Parveen B., Basist P., Parveen A., Gaurav, et al. Indian medicinal plants and formulations and their potential against COVID-19–preclinical and clinical research. Front Pharmacol. 2021 doi: 10.3389/fphar.2020.578970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lade Archana, Deogade Meena, Rajput Dhirajsingh S., Wanjari Anita. Comparative analytical evaluation of Ayurveda oil processing method on sesame and mustard oil. Ann Ayurvedic Med. 2020;9:22–28. [Google Scholar]
- 43.Rubin M., Modai S., Rayman S., Kaplan K.M., Mendelson E., Lichtenberg D. Antiviral properties of goat milk. Clin Nutr Open Sci. 2021;37:1–11. doi: 10.1016/j.nutos.2021.03.002. [DOI] [Google Scholar]
- 44.Duraipandi S., Selvakumar V. Reinventing nano drug delivery systems for hydrophilic active ingredients in Ayurvedic lipid based formulations containing poly herbal decoction. J Ayurveda Integr Med. 2020;11:224–227. doi: 10.1016/j.jaim.2018.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Thakur V., Paroha S., Mishra R.P. Free fatty acid profile of seven sesame (Sesamum indicum L.) verities. Int J Curr Microbiol Appl Sci. 2018 doi: 10.20546/ijcmas.2018.707.399. [DOI] [Google Scholar]
- 46.Çakır B., Okuyan B., Şener G., Tunali-Akbay T. Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): in silico analysis. Eur J Pharmacol. 2021 doi: 10.1016/j.ejphar.2020.173781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pena-Serna C., Restrepo-Betancur L.F. Chemical, physicochemical, microbiological and sensory characterization of cow and buffalo ghee. Food Sci Technol. 2020;40(3) doi: 10.1590/fst.32219. [DOI] [Google Scholar]
- 48.Khan Mohd Umar, Hassan Mohammad Fahimul, Rauf Abdul. Effect of temperature on milk fats of cow, buffalo, and goat used for frying local food products. Food Qual Saf. March 2018;2(1):51–57. doi: 10.1093/fqsafe/fyx029. [DOI] [Google Scholar]